| Literature DB >> 36141949 |
Carlos Hernández-Pascual1,2, José Ángel Santos-Sánchez3, Jorge Hernández-Rodríguez3, Carlos Fernando Silva-Viamonte4, Carmen Pablos-Hernández5, Manuel Villanueva-Martínez6, José Antonio Mirón-Canelo7.
Abstract
There is no universal postoperative classification of extracapsular hip fractures (ECFs). We wondered if infection (according to infection after fracture fixation criteria (IAFF)), immediate partial weight bearing (PWB) and/or the new GammaTScore tool could predict early cut-out. We also examined the correlation between GammaTScore and time to consolidation and studied long-term survival. This was a retrospective cohort study of low-energy complete ECFs operated with Gamma3T nailing in 2014 and fully monitoring, in patients aged over 65. Ten not distally locked cases, one late cut-out, one cut-through, one osteonecrosis and one pseudarthrosis were discarded. Patients were classified into early cut-out (7/204; 3.55%) and no early cut-out (197/204; 96.45%). There was a lower percentage of A2 fractures according to the AO Foundation/Orthopaedic Trauma Association classification (AO/OTA, 1997) in early cut-out. IAFF and only the GammaTScore reduction parameter were different for early cut-out, in opposition to immediate PWB, tip-to-apex distance (TAD) or the Baumgaertner-Fogagnolo classification. GammaTScore inversely correlated with consolidation (p < 0.01). Long-term survival time was not statistically significantly lower in the early cut-out group. Small sample of cases may limit our results. Apart from an important role of IAFF, GammaTScore would be useful for predicting consolidation, avoiding complications and reducing costs. Further studies are needed for reliability.Entities:
Keywords: complications; fracture fixation; hip fracture; intramedullary; risk factor; surgery; treatment outcome
Mesh:
Year: 2022 PMID: 36141949 PMCID: PMC9517159 DOI: 10.3390/ijerph191811680
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Figure 1Organization chart (ECF, extracapsular fracture; HUS, Hospital Universitario de Salamanca; Sx., surgery.).
Figure 2GammaTScore scoring system.
Figure 3GammaTScore algorithm obtention chart.
Tests: a, Fisher’s exact test; c, Mann–Whitney U test (TAD, tip-to-apex distance; IAFF, infection after fracture fixation; Sx., surgery; PWB, partial weight bearing). *, Statistically significative.
| Variable | Early Cut-Out | No early Cut-Out |
|
|---|---|---|---|
| Number of patients | 7 | 197 | |
| TAD | 25.54 (SD 8.81) | 22.67 (SD 6.44) | 0.395 c |
| Baumgaertner–Fogagnolo | |||
| Poor | 1 (14.3%) | 7 (3.6%) | 0.072 a |
| Moderate | 4 (57.1%) | 64 (32.5%) | |
| Good | 2 (28.6%) | 126 (64.0%) | |
| Infection (IAFF) * | 0.002 a, * | ||
| -No | 4 (57.2%) | 191 (96.9%) | |
| -Yes | 3 (42.8%) | 6 (3.1%) | |
| Immediate post-Sx. PWB | 0.451 a | ||
| -No | 5 (71.4%) | 103 (52.8%) | |
| -Yes | 2 (28.6%) | 94 (47.2%) |
Figure 4Representation of results of the GammaTScore tool, from top to bottom and from left to the right: (a) GammaTScore parameter—reduction; (b) GammaTScore parameter—osteosynthesis; (c) GammaTScore parameter—instability; (d) GammaTScore final rate. *, Statistically significative.
Preoperative variables. Tests: a, Fisher’s exact test; b, Pearson’s chi-square test; c, Mann–Whitney’s U test; d, median test (Sx., surgery; CMI, Charlson’s comorbidity index; OP, osteoporosis; Fx., fracture; APT, anti-platelet therapy; ACT, anti-coagulation therapy; AAS, acetylsalicylic acid; LMWH, low-molecular-weight heparin; ASA, American Society of Anesthesiologists). # Upon admission, no calcium and/or vitamin D.
| Variable | Early Cut-Out | No Early Cut-Out |
|
|---|---|---|---|
| Age (years-old) | 83 (SD 10.31) (65;99) | 85.82 (SD 6.59) (65;103) | 0.512 c |
| Sex | 0.640 a | ||
| -Female | 5 (71.4%) | 156 (79.2%) | |
| -Male | 2 (28.6%) | 41 (20.8%) | |
| Side | 1.000 a | ||
| -Left | 3 (42.4%) | 81 (41.1%) | |
| -Right | 4 (57.6%) | 116 (58.9%) | |
| Social situation | 0.121 a | ||
| -Home, alone | 3 (42.9%) | 26 (13.2%) | |
| -Home, not alone | 3 (42.9%) | 104 (52.8%) | |
| -Institutionalized | 1 (14.3%) | 67 (34.0%) | |
| Dependency | |||
| -Barthel pre-Sx. | 86.43 (SD 16.51) (55;100) | 75.28 (SD 21.57) (10;100) | 0.150 c |
| -Barthel post-Sx. | 43.57 (SD 21.74) (15;75) | 46.78 (SD 20.93) (10;85) | 0.697 c |
| Comorbidity | |||
| -Non-age-adjusted CMI | 2.57 (SD 1.13) (1;4) | 2.15 (SD 1.29) (0;7) | 0.293 c |
| -Age-adjusted CMI | 6.42 (SD 1.27) (5;8) | 6.11 (SD 1.30) (4;11) | 0.467 c |
| Cognitive status | 1.000 a | ||
| -None | 1 (14.3%) | 33 (16.8%) | |
| -Mild | 5 (71.4%) | 130 (66.0%) | |
| -Moderate | 1 (14.3%) | 33 (16.8%) | |
| -Severe | 0 (0%) | 1 (0.5%) | |
| Previous Fx. | 1.000 a | ||
| -None | 5 (71.4%) | 114 (57.9%) | |
| -Traumatic | 0 (0%) | 6 (3.0%) | |
| -OP fracture | |||
| --Hip | 0 (0%) | 15 (7.6%) | |
| --Other locations | 2 (28.6%) | 54 (27.4%) | |
| --Both locations | 0 (0%) | 8 (4.1%) | |
| OP treatment # | 0.596 b | ||
| -No | 129 (85.4%) | 47 (82.5%) | |
| -Yes | 22 (14.6%) | 10 (17.5%) | |
| APT/ACT | 0.882 a | ||
| -None | 5 (71.4%) | 110 (55.8%) | |
| -AAS 100 | 2 (28.6%) | 39 (19.8%) | |
| -AAS 300 | 0 (0%) | 17 (8.6%) | |
| -Clopidogrel | 0 (0%) | 1 (0.5%) | |
| -Acenocumarol | 0 (0%) | 26 (13.2%) | |
| -Direct Xa | 0 (0%) | 2 (2.0%) | |
| -LMWH | 0 (0%) | 2 (2.0%) | |
| ASA | 3 (1;4) | 3 (1;4) | 0.503 d |
Perioperative variables. Tests: a, Fisher’s exact test; b, Pearson’s chi-square test; c, Mann–Whitney’s U test (AO/OTA, AO Foundation/Orthopaedic Trauma Association classification; Sx., surgery; [RBC], red blood cells concentrate). *, Statistically significative.
| Variable | Early Cut-Out | No Early Cut-Out |
|
|---|---|---|---|
| Jensen | 0.345 a | ||
| Stability (Jensen) | 0.713 a | ||
| -Stable (I + II) | 3 (42.9%) | 73 (37.1%) | |
| -Unstable (III + IV + V) | 4 (57.1%) | 124 (62.9%) | |
| AO/OTA, 2007 * | 0.033 b, * | ||
| -A1 | 3 (42.9%) | 59 (29.9%) | |
| -A2 | 1 (14.3%) | 111 (56.3%) | |
| -A3 | 2 (28.6%) | 17 (8.6%) | |
| Stability(AO/OTA, 2007) | 0.305 b | ||
| Stable | 3 (42.9%) | 118 (59.9%) | |
| Unstable | 3 (42.9%) | 69 (35.0%) | |
| Basicervical (B2.1) | 1 (14.3%) | 10 (5.1%) | |
| Massoud | 1.000 b | ||
| -Stable | 4 (57.1%) | 68 (34.5%) | |
| -Unstable | 3 (42.9%) | 129 (65.5%) | |
| Average stay (days) | 9.57 (SD 2.63) (6;13) | 9.71 (SD 3.36) (4;26) | 0.880 c |
| Pre-Sx. stay (days) | 3.00 (SD 2.00) (0;5) | 3.30 (SD 2.56) (0;9) | 0.749 c |
| Post-Sx. stay (days) | 6.57 (SD 2.22) (3;9) | 6.37 (SD 2.79) (3;25) | 0.431 c |
| Blood loss (g/dl Hb) | 1.42 (SD 1.16) (0;3.0) | 1.92 (SD 1.75) (−3.5;5.9) | 0.323 c |
| Transfusions [RBC] | 1.85 (SD 1.67) (0;5) | 1.35 (SD 1.37) (0;8) | 0.427 c |
Summary of the early cut-out cohort. (M, male; F, female; AO/OTA, AO Foundation/Orthopaedic Trauma Association classification; PWB, partial weight bearing; IAFF, infection after fracture fixation; ROM, removal of osteosynthesis material; PHA, partial hip arthroplasty; THA, total hip arthroplasty).
| No. | Sex/(Age) | Jensen Stability | AO/OTA (1997) Stability | Massoud Stability | Immediate PWB | Detection Grade | IAFF (Weeks) | Consolidation/Reintervention (Weeks) | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Yes | No | Yes | No | 2.1 | Yes | No | ||||||
|
| M (88) |
|
|
|
|
|
|
| Yes | III | Yes (10.0) | No/ROM |
|
| F (88) |
|
|
|
|
|
|
| No | III | Yes (0.71) | No/ROM |
|
| F (79) |
|
|
|
|
|
|
| No | II | Yes (29.4) | Yes/ROM |
|
| M (77) |
|
|
|
|
|
|
| No | II | No | No/PHA |
|
| F (65) |
|
|
|
|
|
|
| No | III | No | No/THA |
|
| F (87) |
|
|
|
|
|
|
| No | I | No | Yes/- |
|
| F (97) |
|
|
|
|
|
|
| Yes | III | No | No/PHA |